Riboflavin supplements for blood pressure lowering in adults.
- 2025-10-22
- Meta-Analysis · n = 320
- The Cochrane database of systematic reviews 2025(10)
- Kathryn E Bradbury
- Sean Coffey
- Nikki Earle
- Cliona Ni Mhurchu
- Andrew B Jull
- PubMed: 41123035
- DOI: 10.1002/14651858.cd015464.pub2
- High evidence
- Adults
there were two adverse events in the riboflavin group and one in the control group. Low-certainty evidence suggests that riboflavin may result in little to no difference in adverse events.
- Effect
- Neutral
- Effect size
- Small